Summary
Raytheon Technologies Corporation reported solid financial performance for the second quarter and first half of 2022, demonstrating revenue growth driven by its Collins Aerospace and Pratt & Whitney segments, with commercial aerospace recovery being a key contributor. Net sales for the second quarter increased by 3% to $16.3 billion, and for the six months increased by 3% to $32.0 billion, compared to the prior year periods. Net income attributable to common shareholders also saw an increase, reaching $1.3 billion ($0.88 per diluted share) for the quarter and $2.4 billion ($1.60 per diluted share) for the six months. The company continues to navigate a complex operating environment, including ongoing impacts from global sanctions on Russia and supply chain constraints, which affected certain segments. Despite these challenges, Raytheon Technologies maintained a strong financial position with significant cash and cash equivalents, supported by robust operating cash flows and ample liquidity from its credit facilities. The company also continued its commitment to shareholder returns through dividends and share repurchases.
Financial Highlights
54 data points| Revenue | $16.31B |
| R&D Expenses | $698.00M |
| SG&A Expenses | $1.42B |
| Operating Expenses | $14.98B |
| Operating Income | $1.35B |
| Interest Expense | $329.00M |
| Net Income | $1.30B |
| EPS (Basic) | $0.88 |
| EPS (Diluted) | $0.88 |
| Shares Outstanding (Basic) | 1.48B |
| Shares Outstanding (Diluted) | 1.49B |
Key Highlights
- 1Total net sales increased by 2.7% to $16.3 billion in Q2 2022 and by 2.9% to $32.0 billion in the first half of 2022, year-over-year.
- 2Net income attributable to common shareowners increased to $1.3 billion ($0.88/share) in Q2 2022 and $2.4 billion ($1.60/share) in the first half of 2022.
- 3Collins Aerospace and Pratt & Whitney segments showed significant sales growth, driven by the recovery in commercial aerospace, including increased aftermarket sales and OEM volume.
- 4The company maintained a strong liquidity position with $4.8 billion in cash and cash equivalents and $7.0 billion in available revolving credit facilities as of June 30, 2022.
- 5Research and development expenses increased, with company-funded R&D representing 4.3% of net sales in Q2 2022, reflecting ongoing investment in innovation.
- 6Significant share repurchases of $1.8 billion were made in the first half of 2022, alongside dividend payments, demonstrating a commitment to returning capital to shareholders.
- 7The company faced challenges related to global sanctions on Russia, resulting in certain charges and reversals of remaining performance obligations (RPO).